T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 3,265.00
+10.00 (0.31%)
At close: Mar 13, 2026
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 155.31 billion as of March 13, 2026. Its market cap has increased by 82.72% in one year.
Market Cap
155.31B
Enterprise Value
198.07B
Revenue
20.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,265.00
Market Cap Chart
Since November 28, 2018, T&R Biofab's market cap has increased from 101.48B to 155.31B, an increase of 53.05%. That is a compound annual growth rate of 6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 155.31B | -13.37% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ToolGen | 434.73B |
| InBody Co.,Ltd | 360.89B |
| Bio Plus | 300.93B |
| DRTECH | 161.95B |
| Osang Healthcare Co.,Ltd | 135.03B |
| P&S Robotics | 109.62B |
| LabGenomics | 106.16B |
| Gencurix | 87.27B |